Jan-willem B. De Groot

Zwolle, OV, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study.

Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: May 18, 2026

Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy.

Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 14, 2026

Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer: The ORCHESTRA Randomized Clinical Trial.

Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer: The ORCHESTRA Randomized Clinical Trial.

Journal: JAMA
Published: March 16, 2026

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.

Journal: The New England journal of medicine
Published: June 03, 2024

Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial.

Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial.

Journal: JAMA surgery
Published: February 14, 2024

Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study.

Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study.

Journal: International journal of cancer
Published: December 01, 2023

Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial.

Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial.

Journal: Acta oncologica (Stockholm, Sweden)
Published: October 28, 2023

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

Journal: EClinicalMedicine
Published: September 11, 2023

Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies.

Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies.

Journal: European journal of cancer (Oxford, England : 1990)
Published: January 12, 2023

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.

Journal: BMC cancer
Published: December 20, 2022

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Journal: The New England journal of medicine
Published: December 08, 2022

Added value of digital FDG-PET/CT in disease staging and restaging in patients with resectable or borderline resectable pancreatic cancer.

Added value of digital FDG-PET/CT in disease staging and restaging in patients with resectable or borderline resectable pancreatic cancer.

Journal: Surgical oncology
Published: November 16, 2022
Showing 1-12 of 29

Last Updated: 09/26/2026